SCHEMBL9708162

SCHEMBL9708162

CC(C)Cn1c(=O)c2c(nc(CC(C)(C)C)n2Cc2ccc(-c3ccccc3-c3nnn[nH]3)cc2)n(C)c1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 1/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
NPSR1 Q6W5P4 5/20 0.40
TSHR P16473 4/20 0.40
LMNA P02545 3/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
CASP1 P29466 2/20 0.40
HSD17B10 Q99714 2/20 0.40
ALOX15 P16050 1/20 0.40
ADORA3 P0DMS8 2/20 0.39
ADORA1 P30542 2/20 0.39
ADORA2A P29274 1/20 0.39
ADORA2B P29275 1/20 0.39
HTT P42858 2/20 0.39
CASP7 P55210 1/20 0.39
DPP4 P27487 1/20 0.39
ALDH1A1 P00352 5/20 0.39
USP2 O75604 1/20 0.38
PDE1A P54750 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9709079 0.94 PDE1A (0.43) NPSR1TSHRLMNASMN1; SMN2CASP1
SCHEMBL9708158 0.94 ADORA3 (0.41) ADORA3ADORA1ADORA2AADORA2BPDE1A
SCHEMBL9708090 0.92 ADORA3 (0.39) ADORA3ADORA1ADORA2A
SCHEMBL9708576 0.92 ADORA1 (0.40) ADORA3ADORA1ADORA2AADORA2B
SCHEMBL9708497 0.91 RAB9A (0.43) RAB9AMEN1KMT2ANPSR1TSHR
SCHEMBL9708646 0.91 ALOX15 (0.41) NPSR1TSHRSMN1; SMN2HSD17B10ALOX15
SCHEMBL9707973 0.91 ADORA1 (0.42) RAB9AMEN1KMT2ANPSR1TSHR
SCHEMBL9708878 0.91 ALOX15 (0.41) NPSR1TSHRHSD17B10ALOX15ADORA3
SCHEMBL9708473 0.90 ADORA3 (0.37) ADORA3ADORA1ADORA2AADORA2BALDH1A1
SCHEMBL9708448 0.90 ADORA3 (0.40) ADORA3ADORA1ADORA2AADORA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992007852-A1 BIPHENYLALKYL XANTHINE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1992-05-14 WO disclosed